Literature DB >> 33434714

Noninvasively immunogenic sonodynamic therapy with manganese protoporphyrin liposomes against triple-negative breast cancer.

Huaqing Chen1, Lanlan Liu1, Aiqing Ma2, Ting Yin1, Ze Chen1, Ruijing Liang1, Yuzhi Qiu3, Mingbin Zheng4, Lintao Cai5.   

Abstract

Sonodynamic therapy (SDT) is a promising approach for tumor treatment because of the noninvasion, and future would be perfect while it activates systemic immune responses through deep penetration to effectively avoid tumor recurrence. Here, a multifunctional nanosonosensitizer system (FA-MnPs) is designed by encapsulating manganese-protoporphyrin (MnP) into folate-liposomes. The nanoparticles of FA-MnPs not only exhibit excellent depth-responsive SDT but also simultaneously activate SDT-mediated immune response. Under US irradiation, FA-MnPs show the high acoustic intensity in mimic tissue up to 8 cm depth and generate amount of singlet oxygen (1O2). Density functional theory (DFT) calculations reveal that metal coordination in MnP has enhanced the US response ability. The good depth-responsed SDT of FA-MnPs efficiently suppresses the growth of not only the superficial tumors but also the deep lesion in the triple-negative breast cancer (TNBC) mice model. Importantly, FA-MnPs-induced SDT further re-polarizes immunosuppressive M2 macrophages to antitumor M1 macrophages, and elicits immunogenic cell death (ICD) to activate dendritic cells, T lymphocytes, and natural killercells (NK), which consequently trigger the antitumor immune, contributing to the tumor growth inhibition. This study put forward an idea for curing deep-seated and metastatic tumors through noninvasively depth-irradiated immunogenic SDT by reasonably designing multifunctional sonosensitizers.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Deep penetration; Immunogenic cell death; Manganese protoporphyrin; Noninvasive therapy; Sonodynamic therapy

Mesh:

Substances:

Year:  2021        PMID: 33434714     DOI: 10.1016/j.biomaterials.2020.120639

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  17 in total

Review 1.  Recent advances in sonodynamic immunotherapy.

Authors:  Hui Wang; Guo-Qing Sui; Zhi-Xia Sun; Jia-Rui Du; Yang Wang; Zong-Hua Yue; Han-Yu Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2022-07-13       Impact factor: 4.322

2.  Cavitation assisted endoplasmic reticulum targeted sonodynamic droplets to enhanced anti-PD-L1 immunotherapy in pancreatic cancer.

Authors:  Jifan Chen; Liting Feng; Peile Jin; Jiaxin Shen; Jiayue Lu; Yue Song; Guowei Wang; Qin Chen; Deyi Huang; Ying Zhang; Chao Zhang; Youfeng Xu; Pintong Huang
Journal:  J Nanobiotechnology       Date:  2022-06-16       Impact factor: 9.429

3.  Multifunctional Lipid Bilayer Nanocarriers for Cancer Immunotherapy in Heterogeneous Tumor Microenvironments, Combining Immunogenic Cell Death Stimuli with Immune Modulatory Drugs.

Authors:  André E Nel; Kuo-Ching Mei; Yu-Pei Liao; Xiangsheng Liu
Journal:  ACS Nano       Date:  2022-03-29       Impact factor: 18.027

Review 4.  Sonodynamic therapy: Rapid progress and new opportunities for non-invasive tumor cell killing with sound.

Authors:  Katherine M Nowak; Mark R Schwartz; Victoria R Breza; Richard J Price
Journal:  Cancer Lett       Date:  2022-02-11       Impact factor: 9.756

Review 5.  Nanomaterial-assisted CRISPR gene-engineering - A hallmark for triple-negative breast cancer therapeutics advancement.

Authors:  Jabeen Farheen; Narayan S Hosmane; Ruibo Zhao; Qingwei Zhao; M Zubair Iqbal; Xiangdong Kong
Journal:  Mater Today Bio       Date:  2022-10-04

Review 6.  Application progress of RVG peptides to facilitate the delivery of therapeutic agents into the central nervous system.

Authors:  Qinghua Wang; Shang Cheng; Fen Qin; Ailing Fu; Chen Fu
Journal:  RSC Adv       Date:  2021-02-24       Impact factor: 3.361

7.  Gene augmented nuclear-targeting sonodynamic therapy via Nrf2 pathway-based redox balance adjustment boosts peptide-based anti-PD-L1 therapy on colorectal cancer.

Authors:  Guoyun Wan; Xuheng Chen; Haijiao Wang; Shenglei Hou; Qian Wang; Yuanyuan Cheng; Qian Chen; Yingge Lv; Hongli Chen; Qiqing Zhang
Journal:  J Nanobiotechnology       Date:  2021-10-29       Impact factor: 10.435

Review 8.  Dual-Targeting and Stimuli-Triggered Liposomal Drug Delivery in Cancer Treatment.

Authors:  Nour AlSawaftah; William G Pitt; Ghaleb A Husseini
Journal:  ACS Pharmacol Transl Sci       Date:  2021-06-01

9.  An Urchin-Shaped Copper-Based Metalloporphyrin Nanosystem as a Sonosensitizer for Sonodynamic Therapy.

Authors:  Aiqing Ma; Hui Ran; Jiaxing Wang; Rui Ding; Chengyu Lu; Lanlan Liu; Yingmei Luo; Huaqing Chen; Ting Yin
Journal:  Nanomaterials (Basel)       Date:  2022-01-10       Impact factor: 5.076

Review 10.  Immunotherapy for Triple-Negative Breast Cancer.

Authors:  Yifeng Cao; Chuyang Chen; Yi Tao; Weifeng Lin; Ping Wang
Journal:  Pharmaceutics       Date:  2021-11-25       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.